- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Cyclotron.
Displaying page 1 of 1.
EudraCT Number: 2018-002343-29 | Sponsor Protocol Number: CRCSV2A18 | Start Date*: 2020-08-11 | |||||||||||
Sponsor Name:Service of Neurology, CHU Liege | |||||||||||||
Full Title: Synaptic modifications in subjective cognitive decline. A study using [18F]UCB-H, a synaptic vesicle 2A radiotracer. | |||||||||||||
Medical condition: Neurodegenerative Cognitive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001599-12 | Sponsor Protocol Number: 18F-AV-45-C01 | Start Date*: 2014-03-04 |
Sponsor Name:VU University Medical Center (VUmc) | ||
Full Title: The clinical value of amyloid imaging with [18F]-AV45 in a population of memory clinic patients | ||
Medical condition: The total number of inclusion in this study is 170 subjects; 140 patients (including Alzheimer’s disease (AD) patients, patients with mild cognitive impairment (MCI), patients with subjective memor... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006833-29 | Sponsor Protocol Number: BPS-MR-PAH-202Amendment1Ireland | Start Date*: 2009-06-29 | |||||||||||
Sponsor Name:Lung LLC | |||||||||||||
Full Title: An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004629-96 | Sponsor Protocol Number: S-20130147 | Start Date*: 2014-06-13 | |||||||||||
Sponsor Name:Department of Nuclear Medicine, Odense University Hospital | |||||||||||||
Full Title: Diagnostic Modalities in Nuclear Medicine in Well-Differentiated Thyroid Cancer | |||||||||||||
Medical condition: Well-differentiated Thyroid Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002480-15 | Sponsor Protocol Number: M14REP | Start Date*: 2014-10-15 | ||||||||||||||||
Sponsor Name:The Dutch Working Group on Immunotherapy of Oncology (WIN-O) | ||||||||||||||||||
Full Title: A Phase II, Open-Label, Multicenter Study of Vemurafenib plus Cobimetinib (GDC-0973) in Unresectable Stage IIIc or Metastatic Melanoma; Response Monitoring and Resistance Prediction with Positron E... | ||||||||||||||||||
Medical condition: BRAFV600-mutation positive patients with unresectable stage IIIc or IV melanoma. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004937-29 | Sponsor Protocol Number: NL55621.029.15 | Start Date*: 2016-06-14 | ||||||||||||||||
Sponsor Name:VU University Medical Center | ||||||||||||||||||
Full Title: Towards early identification of response to CABAZItaxel in patients with metastatic castration-resistant prostate cancer: potential of 18F-Choline PET-CT (CABAZIPET). | ||||||||||||||||||
Medical condition: Metastatic castration-resistant prostate cancer. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-005919-30 | Sponsor Protocol Number: AK_NEN_DOTA-FDG_21 | Start Date*: 2022-09-21 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients with Neuroendocrine Neoplasms | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Neuroendocrine neoplasms | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000253-21 | Sponsor Protocol Number: CLA-CC10-02 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Therabron Therapeutics Inc. | |||||||||||||
Full Title: Efficacy of recombinant human club (clara) cell 10kDa protein (CC10) administered to premature neonates with respiratory distress syndrome. | |||||||||||||
Medical condition: Bronchopulmonary Dysplasia (BPD) | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014453-32 | Sponsor Protocol Number: BPS-MR-PAH-204,Amdt2US,BEL,RO | Start Date*: 2010-01-11 | |||||||||||
Sponsor Name:Lung LLC | |||||||||||||
Full Title: An open-label extension of BPS-MR-PAH-203 in pulmonary arterial hypertension (PAH) patients | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IE (Completed) DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003740-36 | Sponsor Protocol Number: ICNAS-P01/2016 | Start Date*: 2019-03-11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:ICNAS Produção Lda. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Comparative study of 68Ga-PSMA-11 PET and 18F-Fluorocholine PET in the detection of Recurrence in Prostate Cancer Patients after Radical Treatment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Prostate Cancer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: PT (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.